These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

632 related items for PubMed ID: 28090793

  • 1. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
    Cui E, Long W, Luo L, Hu M, Huang L, Chen X.
    Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
    [Abstract] [Full Text] [Related]

  • 2. Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic.
    Zhou ZP, Long LL, Qiu WJ, Cheng G, Huang LJ, Yang TF, Huang ZK.
    Abdom Radiol (NY); 2017 Sep; 42(9):2272-2278. PubMed ID: 28396918
    [Abstract] [Full Text] [Related]

  • 3. Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR.
    Talakic E, Steiner J, Kalmar P, Lutfi A, Quehenberger F, Reiter U, Fuchsjäger M, Schöllnast H.
    Eur J Radiol; 2014 Apr; 83(4):607-11. PubMed ID: 24380639
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
    Chen CY, Chen J, Xia CC, Huang ZX, Song B.
    J Biol Regul Homeost Agents; 2017 Apr; 31(4):1029-1036. PubMed ID: 29254310
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnostic value of Gd-EOB-DTPA-enhanced MR cholangiography in non-invasive detection of postoperative bile leakage.
    Kul M, Erden A, Düşünceli Atman E.
    Br J Radiol; 2017 Apr; 90(1072):20160847. PubMed ID: 28181823
    [Abstract] [Full Text] [Related]

  • 10. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral.
    Li XH, Huang R, Yang M, Wang J, Gao YH, Jin Q, Ma DL, Wei L, Rao HY.
    World J Gastroenterol; 2022 May 28; 28(20):2214-2226. PubMed ID: 35721884
    [Abstract] [Full Text] [Related]

  • 11. Improved parenchymal liver enhancement with extended delay on Gd-EOB-DTPA-enhanced MRI in patients with parenchymal liver disease: associated clinical and imaging factors.
    Esterson YB, Flusberg M, Oh S, Mazzariol F, Rozenblit AM, Chernyak V.
    Clin Radiol; 2015 Jul 28; 70(7):723-9. PubMed ID: 25921617
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
    Lin CY, Chang WC, Chou CT, Chen RC.
    J Chin Med Assoc; 2015 Nov 28; 78(11):666-72. PubMed ID: 26341453
    [Abstract] [Full Text] [Related]

  • 14. Hepatobiliary phase images using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI as an imaging surrogate for the albumin-bilirubin grading system.
    Takatsu Y, Kobayashi S, Miyati T, Shiozaki T.
    Eur J Radiol; 2016 Dec 28; 85(12):2206-2210. PubMed ID: 27842668
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.
    Verloh N, Haimerl M, Zeman F, Schlabeck M, Barreiros A, Loss M, Schreyer AG, Stroszczynski C, Fellner C, Wiggermann P.
    Eur Radiol; 2014 May 28; 24(5):1013-9. PubMed ID: 24531844
    [Abstract] [Full Text] [Related]

  • 18. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY, Choi JY, Kim CW, Bae SH, Yoon SK, Lee YJ, Rha SE, You YK, Kim DG, Jung ES.
    Liver Transpl; 2012 Jul 28; 18(7):850-7. PubMed ID: 22407909
    [Abstract] [Full Text] [Related]

  • 19. Potential of Gd-EOB-DTPA as an imaging biomarker for liver injury estimation after radiation therapy.
    Sun XL, Jiang X, Kuang Y, Xing L, Bu LY, Yuan SH, Yu JM, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2019 Aug 28; 18(4):354-359. PubMed ID: 31221569
    [Abstract] [Full Text] [Related]

  • 20. Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis.
    Kim HY, Choi JY, Park CH, Song MJ, Song DS, Kim CW, Bae SH, Yoon SK, Lee YJ, Rha SE.
    J Gastroenterol; 2013 Oct 28; 48(10):1180-7. PubMed ID: 23354621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.